Rhumbline Advisers Talis Biomedical Corp Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.81 - $1.44 $9,236 - $16,420
-11,403 Closed
0 $0
Q1 2022

May 12, 2022
SELL
$1.3 - $4.19 $1,531 - $4,935
-1,178 Reduced 9.36%
11,403 $16,000
Q3 2021

Nov 12, 2021
SELL
$6.02 - $12.46 $2,377 - $4,921
-395 Reduced 3.04%
12,581 $79,000
Q2 2021

Aug 05, 2021
BUY
$9.62 - $14.56 $124,829 - $188,930
12,976 New
12,976 $143,000

About Talis Biomedical Corp

TLIS Quotes by TradingView
  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $47.1M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email